The Emotional Impact of Surveillance for Pancreatic Cancer
The registry record from ClinicalTrials.gov (public domain): summary, interventions, outcomes and eligibility. Questions are answered only with quotes from this document. Source: ClinicalTrials.gov, retrieved 2026-11-05.
Outcome unknown
Record metadata
- Phase
- NA
- Status
- Unknown
- Start
- 2017-07-01
- End
- 2021-12-31
- Enrollment
- 150
- Sites
- 1
- Sponsor class
- OTHER
Not in the data yet: a trial card. A one-glance card (population, design, endpoints, result, each tied to a quote) is not built yet. The fields above are registry or bibliographic metadata, not quotes.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you get that instead of a guess.
Source text
Brief summary · public domain (ClinicalTrials.gov) · T1
Due to its rarity a population screening program for pancreatic cancer is not possible. For this reason, considering background data on genetic predisposition and familiarity for this lethal tumor, efforts have been pushed to build up surveillance programs for subjects at high-risk of pancreatic cancer, due to familiarity and/or genetic predisposition. These programs are based on radiological examinations (such as MRI or endoultrasonography) and laboratory tests. However, little is known about the psychological burden of these programs. Only a handful of studies investigated, in various ways, how the participation in surveillance programs for pancreatic cancer may burden the psychological status, with a consequent possible impairment of the psychological wellbeing, and a higher risk of withdraw from the surveillance program itself. The aim of this study was to assess the psychological and emotional impact in high-risk individuals participating in a surveillance program for pancreatic cancer due to familiarity and/or to genetic predisposition, using specific psychological tools, such as multiple psychological questionnaires, investigating different functioning areas, administered by a clinical psychologist.
Intervention · public domain (ClinicalTrials.gov) · T1
Diagnostic_Test: Barratt Simplified Measure of Social Status (BSMSS). Questionnaire that evaluates cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)
Intervention · public domain (ClinicalTrials.gov) · T1
Diagnostic_Test: Global Assessment of Functioning scale (GAF). Used to measure overall levels of functionality of an individual
Intervention · public domain (ClinicalTrials.gov) · T1
Diagnostic_Test: General Self-Efficacy Scale (GSES). Psychometric scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life
Intervention · public domain (ClinicalTrials.gov) · T1
Diagnostic_Test: Perceived Stress Scale (PSS). To assess the perceived stress
Intervention · public domain (ClinicalTrials.gov) · T1
Diagnostic_Test: Coping Orientation to Problems Experienced (Brief COPE),. It evaluates the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations
Intervention · public domain (ClinicalTrials.gov) · T1
Diagnostic_Test: Multidimensional Scale of Perceived Social Support (MSPSS). to explore the subject's social support system
Arm · public domain (ClinicalTrials.gov) · T1
Psychometric assessment group (experimental): Arms to whom the psychometric assessment will be administered
Primary outcome · public domain (ClinicalTrials.gov) · T1
Barratt Simplified Measure of Social Status. Evaluation of cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any) Time frame: Baseline.
Primary outcome · public domain (ClinicalTrials.gov) · T1
Barratt Simplified Measure of Social Status. Evaluation of cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any) Time frame: 2-years.
Primary outcome · public domain (ClinicalTrials.gov) · T1
Global Assessment of Functioning scale. measure overall levels of functionality of an individual Time frame: Baseline.
Primary outcome · public domain (ClinicalTrials.gov) · T1
Global Assessment of Functioning scale. measure overall levels of functionality of an individual Time frame: 2-years.
Primary outcome · public domain (ClinicalTrials.gov) · T1
General Self-Efficacy Scale. Self-report scale correlated to emotion, optimism, work Time frame: Baseline.
Eligibility · public domain (ClinicalTrials.gov) · T1
Inclusion Criteria: * Being enrolled in the Institutional surveillance program for pancreatic cancer * Ability to understand the details and implications of a study protocol. Exclusion Criteria: * None
Enrollment · public domain (ClinicalTrials.gov) · T1
Enrollment: 150 participants (actual).